ID

29189

Beschreibung

Phenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study Population; ODM derived from: https://clinicaltrials.gov/show/NCT00964184

Link

https://clinicaltrials.gov/show/NCT00964184

Stichworte

  1. 05.03.18 05.03.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

5. März 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes Mellitus, Type 2 NCT00964184

Eligibility Diabetes Mellitus, Type 2 NCT00964184

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
young (18 to 40 years) patients with diabetes (not on insulin therapy) during the past 6 months and having bmi <25 kg/m2.
Beschreibung

Age | Diabetes | Insulin regime Absent | Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0011847
UMLS CUI [3,1]
C0557978
UMLS CUI [3,2]
C0332197
UMLS CUI [4]
C1305855
drug naïve patients
Beschreibung

Patients Therapy naive

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0919936
patients on mono-therapy with metformin (< 1g/day).
Beschreibung

Metformin U/day

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0456683
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes
Beschreibung

Diabetes Mellitus, Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011854
type 2 diabetes on any other oral hypoglycemic agent other than metformin
Beschreibung

Diabetes Mellitus, Non-Insulin-Dependent | Oral hypoglycemic Except Metformin

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0359086
UMLS CUI [2,2]
C0332300
UMLS CUI [2,3]
C0025598
pregnancy or lactation
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
insulin or sulfonylurea treatment within the past 3 months
Beschreibung

Insulin | Sulfonylurea

Datentyp

boolean

Alias
UMLS CUI [1]
C0021641
UMLS CUI [2]
C0038766
has received any investigational drug with the past 60 days
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
history of prior allergy or hypersensitivity to any drug (unless approved by investigator)
Beschreibung

Drug Allergy

Datentyp

boolean

Alias
UMLS CUI [1]
C0013182
hba1c < 7.5% or > 8.5%.
Beschreibung

Glucohemoglobin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0202054
unstable glycemic control, requiring addition of 2nd oral agent/insulin or frequent up-titration of dose of metformin.
Beschreibung

Glycaemia control Unstable | Requirement Oral medication second | Requirement Insulin second | Metformin Agent Dose Increased

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3267174
UMLS CUI [1,2]
C0443343
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C0175795
UMLS CUI [2,3]
C0205436
UMLS CUI [3,1]
C1514873
UMLS CUI [3,2]
C0021641
UMLS CUI [3,3]
C0205436
UMLS CUI [4,1]
C0025598
UMLS CUI [4,2]
C2348005
any patient on insulin.
Beschreibung

Insulin

Datentyp

boolean

Alias
UMLS CUI [1]
C0021641
females of child bearing potential who are not using adequate contraception during the study period.
Beschreibung

Childbearing Potential Contraceptive methods Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0332197
insulin dependent or history of ketoacidosis requiring hospitalization
Beschreibung

Insulin Dependence | Ketoacidosis Hospitalization Required

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0439857
UMLS CUI [2,1]
C0220982
UMLS CUI [2,2]
C1708385
acute infections
Beschreibung

Communicable Diseases

Datentyp

boolean

Alias
UMLS CUI [1]
C0009450
advanced end-organ damage (cld, crf etc.)
Beschreibung

End organ damage Advanced | Chronic liver disease | Kidney Failure, Chronic

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0743496
UMLS CUI [1,2]
C0205179
UMLS CUI [2]
C0341439
UMLS CUI [3]
C0022661
diabetes with clinically significant or advanced end-organ damage
Beschreibung

Diabetes | End organ damage | End organ damage Advanced

Datentyp

boolean

Alias
UMLS CUI [1]
C0011847
UMLS CUI [2]
C0743496
UMLS CUI [3,1]
C0743496
UMLS CUI [3,2]
C0205179

Ähnliche Modelle

Eligibility Diabetes Mellitus, Type 2 NCT00964184

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age | Diabetes | Insulin regime Absent | Body mass index
Item
young (18 to 40 years) patients with diabetes (not on insulin therapy) during the past 6 months and having bmi <25 kg/m2.
boolean
C0001779 (UMLS CUI [1])
C0011847 (UMLS CUI [2])
C0557978 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C1305855 (UMLS CUI [4])
Patients Therapy naive
Item
drug naïve patients
boolean
C0030705 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
Metformin U/day
Item
patients on mono-therapy with metformin (< 1g/day).
boolean
C0025598 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | Oral hypoglycemic Except Metformin
Item
type 2 diabetes on any other oral hypoglycemic agent other than metformin
boolean
C0011860 (UMLS CUI [1])
C0359086 (UMLS CUI [2,1])
C0332300 (UMLS CUI [2,2])
C0025598 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Insulin | Sulfonylurea
Item
insulin or sulfonylurea treatment within the past 3 months
boolean
C0021641 (UMLS CUI [1])
C0038766 (UMLS CUI [2])
Investigational New Drugs
Item
has received any investigational drug with the past 60 days
boolean
C0013230 (UMLS CUI [1])
Drug Allergy
Item
history of prior allergy or hypersensitivity to any drug (unless approved by investigator)
boolean
C0013182 (UMLS CUI [1])
Glucohemoglobin measurement
Item
hba1c < 7.5% or > 8.5%.
boolean
C0202054 (UMLS CUI [1])
Glycaemia control Unstable | Requirement Oral medication second | Requirement Insulin second | Metformin Agent Dose Increased
Item
unstable glycemic control, requiring addition of 2nd oral agent/insulin or frequent up-titration of dose of metformin.
boolean
C3267174 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C1514873 (UMLS CUI [2,1])
C0175795 (UMLS CUI [2,2])
C0205436 (UMLS CUI [2,3])
C1514873 (UMLS CUI [3,1])
C0021641 (UMLS CUI [3,2])
C0205436 (UMLS CUI [3,3])
C0025598 (UMLS CUI [4,1])
C2348005 (UMLS CUI [4,2])
Insulin
Item
any patient on insulin.
boolean
C0021641 (UMLS CUI [1])
Childbearing Potential Contraceptive methods Absent
Item
females of child bearing potential who are not using adequate contraception during the study period.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Insulin Dependence | Ketoacidosis Hospitalization Required
Item
insulin dependent or history of ketoacidosis requiring hospitalization
boolean
C0021641 (UMLS CUI [1,1])
C0439857 (UMLS CUI [1,2])
C0220982 (UMLS CUI [2,1])
C1708385 (UMLS CUI [2,2])
Communicable Diseases
Item
acute infections
boolean
C0009450 (UMLS CUI [1])
End organ damage Advanced | Chronic liver disease | Kidney Failure, Chronic
Item
advanced end-organ damage (cld, crf etc.)
boolean
C0743496 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0341439 (UMLS CUI [2])
C0022661 (UMLS CUI [3])
Diabetes | End organ damage | End organ damage Advanced
Item
diabetes with clinically significant or advanced end-organ damage
boolean
C0011847 (UMLS CUI [1])
C0743496 (UMLS CUI [2])
C0743496 (UMLS CUI [3,1])
C0205179 (UMLS CUI [3,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video